Freeline Therapeutics Holdings plc
Initiate first-in-human dose finding studies for FLT201
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- December 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Freeline currently expects to initiate first-in-human dose finding studies of FLT201 in late 2021.”
What we found
Evidence strength A What the grades mean
The company initiated the Phase 1/2 GALILEO-1 dose-finding clinical trial for FLT201 in December 2021, meeting the commitment to initiate first-in-human studies by late 2021.
-
A Freeline Therapeutics Holdings plc 6-K filed 2022-01-06
“Freeline initiated the Phase 1/2 dose-finding trial of FLT201 at the end of 2021 in Europe” ✓ confirmed on the page
-
A Freeline Therapeutics Holdings plc 20-F filed 2022-03-31
“we initiated the Phase 1/2 GALILEO-1 dose-finding clinical trial for this program in December 2021.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- FLT201 first-in-human study
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Freeline Therapeutics Holdings plc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C810031-023228 · Corrections policy